When it comes to the three biotech stocks featured in today’s article, all of which have experienced recent struggles, the author notes that their management… Read More »These 3 Struggling Biotechs Could Experience Spring Bumps
What are the top biotech stocks for the second quarter with the best value? What about the top biotech stocks for Q2 with the fastest… Read More »The Top Value, Growth And Momentum Biotech Stocks For Q2
Mathematician, billionaire hedge fund manager and quantitative trading genius Jim Simons, one of the greatest investors of all time, recently staked new positions in two… Read More »2 Compelling Biotech Picks From This Trading Genius
Both of the biotech stocks highlighted in today’s article have potential game-changer drugs being reviewed for approval by the FDA – one that could delay… Read More »Are These 2 Biotech Stocks With Potential Game-Changer Drugs Being Reviewed For Approval Buys?
When it comes to the biotech stocks that experienced strong growth in 2020, the author of today’s article notes that the “more obvious cases such… Read More »3 Biotech Stocks To Watch As 2021 Gets Underway
The Shelton Green Alpha Fund is up more than 100% year-to-date and is among the best-performing funds of 2020 – and a big reason for… Read More »The Co-Managers Of An Outperforming Fund Share 3 Biotech Firms Poised To Solve Future Disease Outbreaks
With two innovative cancer treatment candidates that seek to block the “cloaking signal” used by cancer cells to trick the immune system into not attacking… Read More »Blocking Cancer’s “Cloaking Signal” Creates A Massive Opportunity For This Biotech
Today’s article highlights a plethora of new stocks to watch in the biotech, tech, cleantech, psychedelics and cannabis spaces, among others. In regards to the… Read More »New Stocks To Watch In Biotech, Cleantech, Psychedelics & More
Why might investors looking to get in on the next big biotech trend want to consider picking up shares of the company highlighted in today’s… Read More »What Makes This Biotech An Attractive Investment Opportunity? An Impressive Brain Trust, A Supercomputer, The Third-Largest Biotech IPO In History – And More
Since the discovery of insulin almost 100 years ago, there has been no novel therapy introduced for Type 1 diabetes. That could change in the… Read More »An Overlooked Biotech With A Revolutionary Diabetes Drug Creates An Attractive Buying Opportunity